Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro

Oleanolic acid (OA) is a pentacyclic triterpenoid, abundantly found in plants of the <i>Oleaceae</i> family, and is well known for its beneficial pharmacological activities. Previously, we reported the inhibitory effect of OA on mast cell-mediated allergic inflammation. In this study, we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yun-Mi Kang, Hye-Min Kim, Minho Lee, Hyo-Jin An
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/264d7006c45c45f6805bc74fe7212255
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:264d7006c45c45f6805bc74fe7212255
record_format dspace
spelling oai:doaj.org-article:264d7006c45c45f6805bc74fe72122552021-11-11T17:24:59ZOleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro10.3390/ijms2221120001422-00671661-6596https://doaj.org/article/264d7006c45c45f6805bc74fe72122552021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/12000https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Oleanolic acid (OA) is a pentacyclic triterpenoid, abundantly found in plants of the <i>Oleaceae</i> family, and is well known for its beneficial pharmacological activities. Previously, we reported the inhibitory effect of OA on mast cell-mediated allergic inflammation. In this study, we investigated the effects of OA on atopic dermatitis (AD)-like skin lesions and its underlying mechanism of action. We evaluated the inhibitory effect of OA on AD-like responses and the possible mechanisms using a 1-chloro-2,4-dinitrochlorobenzene (DNCB)-induced AD animal model and tumor necrosis factor (TNF)-α/interferon (IFN)-γ-stimulated HaCaT keratinocytes. We found that OA has anti-atopic effects, including histological alterations, on DNCB-induced AD-like lesions in mice. Moreover, it suppressed the expression of Th2 type cytokines and chemokines in the AD mouse model and TNF-α/IFN-γ-induced HaCaT keratinocytes by blocking the activation of serine-threonine kinase Akt, nuclear factor-κB, and the signal transducer and activator of transcription 1. The results demonstrate that OA inhibits AD-like symptoms and regulates the inflammatory mediators; therefore, it may be used as an effective and attractive therapeutic agent for allergic disorders, such as AD. Moreover, the findings of this study provide novel insights into the potential pharmacological targets of OA for treating AD.Yun-Mi KangHye-Min KimMinho LeeHyo-Jin AnMDPI AGarticleoleanolic acidatopic dermatitis2,4-dinitrochlorobenzenekeratinocyteNF-κBSTAT1Biology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12000, p 12000 (2021)
institution DOAJ
collection DOAJ
language EN
topic oleanolic acid
atopic dermatitis
2,4-dinitrochlorobenzene
keratinocyte
NF-κB
STAT1
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle oleanolic acid
atopic dermatitis
2,4-dinitrochlorobenzene
keratinocyte
NF-κB
STAT1
Biology (General)
QH301-705.5
Chemistry
QD1-999
Yun-Mi Kang
Hye-Min Kim
Minho Lee
Hyo-Jin An
Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
description Oleanolic acid (OA) is a pentacyclic triterpenoid, abundantly found in plants of the <i>Oleaceae</i> family, and is well known for its beneficial pharmacological activities. Previously, we reported the inhibitory effect of OA on mast cell-mediated allergic inflammation. In this study, we investigated the effects of OA on atopic dermatitis (AD)-like skin lesions and its underlying mechanism of action. We evaluated the inhibitory effect of OA on AD-like responses and the possible mechanisms using a 1-chloro-2,4-dinitrochlorobenzene (DNCB)-induced AD animal model and tumor necrosis factor (TNF)-α/interferon (IFN)-γ-stimulated HaCaT keratinocytes. We found that OA has anti-atopic effects, including histological alterations, on DNCB-induced AD-like lesions in mice. Moreover, it suppressed the expression of Th2 type cytokines and chemokines in the AD mouse model and TNF-α/IFN-γ-induced HaCaT keratinocytes by blocking the activation of serine-threonine kinase Akt, nuclear factor-κB, and the signal transducer and activator of transcription 1. The results demonstrate that OA inhibits AD-like symptoms and regulates the inflammatory mediators; therefore, it may be used as an effective and attractive therapeutic agent for allergic disorders, such as AD. Moreover, the findings of this study provide novel insights into the potential pharmacological targets of OA for treating AD.
format article
author Yun-Mi Kang
Hye-Min Kim
Minho Lee
Hyo-Jin An
author_facet Yun-Mi Kang
Hye-Min Kim
Minho Lee
Hyo-Jin An
author_sort Yun-Mi Kang
title Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
title_short Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
title_full Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
title_fullStr Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
title_full_unstemmed Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro
title_sort oleanolic acid alleviates atopic dermatitis-like responses in vivo and in vitro
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/264d7006c45c45f6805bc74fe7212255
work_keys_str_mv AT yunmikang oleanolicacidalleviatesatopicdermatitislikeresponsesinvivoandinvitro
AT hyeminkim oleanolicacidalleviatesatopicdermatitislikeresponsesinvivoandinvitro
AT minholee oleanolicacidalleviatesatopicdermatitislikeresponsesinvivoandinvitro
AT hyojinan oleanolicacidalleviatesatopicdermatitislikeresponsesinvivoandinvitro
_version_ 1718432106132013056